tirzepatide effects on liver approved for T2D, obesity, and OSA management | Amr El-Refaey CMI Level 7 Strategic Management Certificate posted the topic Tirzepatide is a dual incretin

These advantages make it a promising solution for those seeking sustainable weight loss

So we know that all the data we have, our responsibility is to get the right answer to the patient so they can make their own informed decision about the risk and the benefit

Liu et al (232) prepared the MASLD model of blood stasis syndrome by feeding rats with a high-fat and HFFD and intraperitoneally injecting 30 mg/kg STZ

Moreover, there is a potential reduction in the expression of enzymes responsible for the urea cycle, a possible re-establishment of nitrogen equilibrium, and a hypothetical modification or enhancement of nitrogen levels in different tissues

The current study provides support for these findings in a real-world clinical setting, demonstrating that tirzepatide was associated with greater weight reduction than semaglutide in a patient population treated for obesity managementrather than for glycaemic control